Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Curr Opin Microbiol. 2016 May 27;33:13–17. doi: 10.1016/j.mib.2016.05.009

Table 2.

Pharmakokinetic parameters of oxadiazoles compared to linezolida

Drugsb F
(%)
AUC
(μg.min/m
L)
t½β (h) CL
(mL/min/
kg)
Vd
(L/kg)
Tmax
(h)
Cmax
(μg/mL)
2 iv 2,650 22 18.9 0.37
po 100 2,620 40 2 2.5
3 iv 3,520 9.6 5.68 4.73
po 97 4,060 18.6 6 2.34
Linezo
lidc
iv 606 0.55 16.3 0.63
po 72.5 440 0.65 0.33 6.5
a

F - oral bioavailablity; AUC - area under the curve; t½β- terminal half-life; t½elim - elimination half-life; CL – clearance; Vd – Volume of distribution; Tmax – Time at which peak serum concentration was achieved; Cmax – peak serum concentration.

b

Compound 2 was administered iv and po at 50 mg/kg, 3 at 20 mg/kg and linezolid at 10 mg/kg.

c

Data reproduced from Slatter et al. 2002 [29] for comparison.